Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Minica-s - Medication Information

Product NDC Code 49873-401
Drug Name

Minica-s

Type Brand
Pharm Class Allergens [CS],
Cell-mediated Immunity [PE],
Glycerol [CS],
Increased Histamine Release [PE],
Increased IgG Production [PE],
Non-Standardized Chemical Allergen [EPC]
Active Ingredients
Glycerin 80 ml/100ml
Route RECTAL
Dosage Form ENEMA
RxCUI drug identifier 422664,
1242891
Application Number M007
Labeler Name Sato Pharmaceutical Co., Ltd.
Packages
Package NDC Code Description
49873-401-01 2 applicator in 1 carton (49873-401-01) / 8 ml in 1 applicator
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active ingredient Glycerin 80%

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions ■Adults and children 6 years and over: Use 1 rectal enema containing 8 mL of Glycerin daily or as directed by a doctor. Gently insert stem with tip pointing toward navel. Squeeze unit until nearly all liquid is expelled. Remove tip from rectum. ■Children under 6 years: Ask a doctor.

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive ingredients Methylparaben, purified water.

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses For relief of occasional consipation (irregularily). This product generally produces bowel movement in 1/4 to 1 hour.

Purpose

Information about the drug product’s indications for use.
Purpose Laxative

Spl product data elements

Usually a list of ingredients in a drug product.
MINICA-S glycerin METHYLPARABEN WATER GLYCERIN GLYCERIN

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
CARTON

Ask doctor

Information about when a doctor should be consulted about existing conditions or sumptoms before using the drug product, including all warnings for persons with certain preexisting conditions (excluding pregnancy) and all warnings for persons experiencing certain symptoms. The warnings under this heading are those intended only for situations in which consumers should not use the product until a doctor is consulted.
Ask a doctor before use if you have ■abdominal pain, nausea, or vomiting. ■noticed a sudden change in bowel habits that persists over a period of 2 weeks.

Do not use

Information about all contraindications for use. These contraindications are absolute and are intended for situations in which consumers should not use the product unless a prior diagnosis has been established by a doctor or for situations in which certain consumers should not use the product under any circumstances regardless of whether a doctor or health professional is consulted.
Do not use ■for a period of longer than 1 week unless directed by a doctor. Frequent or prolonged use of this preparation may result in dependence on laxatives.

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Other safety information

Information about safe use and handling of the product that may not have been specified in another field.
Other information ■A small amount of liquid will remain in unit. ■Store and use at room temperature.

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if ■you have rectal bleeding or failure to have a bowel movement after use of a laxative. This may indicate a serious condition.

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product ■may cause rectal discomfort or burning sensation.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings For rectal use only Do not use ■for a period of longer than 1 week unless directed by a doctor. Frequent or prolonged use of this preparation may result in dependence on laxatives. Ask a doctor before use if you have ■abdominal pain, nausea, or vomiting. ■noticed a sudden change in bowel habits that persists over a period of 2 weeks. When using this product ■may cause rectal discomfort or burning sensation. Stop use and ask a doctor if ■you have rectal bleeding or failure to have a bowel movement after use of a laxative. This may indicate a serious condition. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API